Pharmacokinetics of FCE 22891, a new oral penem.

FCE 22891 is the oral prodrug of FCE 22101, a new broad-spectrum penem. The pharmacokinetics of FCE 22891 after single-dose administration, its absolute bioavailability, and the effect of food intake on its absorption were investigated in three different randomized crossover studies in healthy volun...

Popoln opis

Bibliografske podrobnosti

izdano v:	Antimicrob Agents Chemother
Principais autores:	Saathoff, A, Lode, H, Hampel, B, Deppermann, K M, Borner, K, Koeppe, P
Format:	Artigo
Jezik:	Inglês
Izdano:	American Society for Microbiology (ASM) 1990
Teme:	Research Article
Online dostop:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC171746/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2203300/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.34.6.1001
Oznake:	Označite Brez oznak, prvi označite!